Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Seiwerth

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Frontiers in Pharmacology|February 7, 2022
Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Acta Pharmacologica Sinica|April 30, 2002
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbancesPredrag Sikiric, Nikola Jelovac, Andjelka Jelovac-Gjeldum, et al.
Current Neuropharmacology|March 15, 2026
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection ApproachIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Frontiers in Pharmacology|December 30, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Digestive Diseases and Sciences|July 24, 2008
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazoleSandra Skorjanec, Zdravko Dolovski, Ivan Kocman, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Inflammopharmacology|July 9, 2024
New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotectionPredrag Sikiric, Marko Sever, Ivan Krezic, et al.
Current Pharmaceutical Design|June 9, 2018
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract HealingPredrag Sikiric, Rudolf Rucman, Branko Turkovic, et al.
Frontiers in Pharmacology|February 7, 2022
Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Acta Pharmacologica Sinica|April 30, 2002
Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbancesPredrag Sikiric, Nikola Jelovac, Andjelka Jelovac-Gjeldum, et al.
Current Neuropharmacology|March 15, 2026
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection ApproachIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Current Neuropharmacology|January 27, 2025
Withdrawn: Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in RatsMarija Medvidovic Grubisic, Sanja Strbe, Ivan Barisic, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in RatsIvan Maria Smoday, Vlasta Vukovic, Katarina Oroz, et al.
Frontiers in Pharmacology|December 30, 2021
Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in RatsMarijan Tepes, Slaven Gojkovic, Ivan Krezic, et al.
Digestive Diseases and Sciences|July 24, 2008
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazoleSandra Skorjanec, Zdravko Dolovski, Ivan Kocman, et al.
Pageof 18